Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × pazopanib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Renal Cell 9 Sarcoma 8 Sarcoma, Clear Cell 2 Neurofibrosarcoma 2 Nerve Sheath Neoplasms 2 Neoplasm Metastasis 2 Liposarcoma 2 Histiocytoma, Angiomatoid Fibrous 2 Granuloma, Plasma Cell 2 Glioblastoma 2 Fibrosarcoma 2 Dermatofibrosarcoma 2 Chondrosarcoma, Extraskeletal Myxoid 2 Vascular Neoplasms 1 Solitary Fibrous Tumors 1 Solid Tumor, Adult 1 Solid Neoplasm 1 Smooth Muscle Tumor 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Perivascular Epithelioid Cell Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neuroendocrine Tumors 1 Neoplasms, Adipose Tissue 1 Myoepithelioma 1 Liposarcoma, Myxoid 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1

Interventions

Gemcitabine 48 pembrolizumab 40 Cisplatin 37 Magnetic Resonance Spectroscopy 23 Specimen Handling 21 Cystectomy 19 Nivolumab 18 enfortumab vedotin 15 durvalumab 15 Carboplatin 14 atezolizumab 13 avelumab 12 Docetaxel 12 Cystoscopy 12 Mitomycin 10 Radiation 8 Paclitaxel 8 Ipilimumab 8 Fluorouracil 8 sacituzumab govitecan 7 Radiotherapy 7 Transurethral Resection of Bladder 6 Standard of Care 6 Platinum 6 Immunoglobulin G 6 Disulfides 6 1,2-diaminocyclohexaneplatinum II citrate 6 erdafitinib 5 cemiplimab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡